These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 17131785
1. Extension of the intensive phase reduces unfavourable outcomes with the 8-month thioacetazone regimen. Van Deun A, Aung KJ, Hamid Salim MA, Ali MA, Naha MS, Das PK, Hossain MA, Declercq E. Int J Tuberc Lung Dis; 2006 Nov; 10(11):1255-61. PubMed ID: 17131785 [Abstract] [Full Text] [Related]
2. Extension of the intensive phase reduces relapse but not failure in a regimen with rifampicin throughout. Aung KJ, Declercq E, Ali MA, Naha S, Datta Roy SC, Taleb MA, Hossain MA, Rigouts L, Gumusboga A, Van Deun A. Int J Tuberc Lung Dis; 2012 Apr; 16(4):455-61. PubMed ID: 22640511 [Abstract] [Full Text] [Related]
3. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R, Borgdorff MW, Sticht-Groh V, Rieder HL, Kawuma HJ, Bretzel G, Rüsch-Gerdes S. East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [Abstract] [Full Text] [Related]
4. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study. Tiwari S, Kumar A, Kapoor SK. Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709 [Abstract] [Full Text] [Related]
5. Early and rapid microscopy-based diagnosis of true treatment failure and MDR-TB. Hamid Salim A, Aung KJ, Hossain MA, Van Deun A. Int J Tuberc Lung Dis; 2006 Nov; 10(11):1248-54. PubMed ID: 17131784 [Abstract] [Full Text] [Related]
6. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group. Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516 [Abstract] [Full Text] [Related]
7. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis? Wilkinson D, Bechan S, Connolly C, Standing E, Short GM. Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111 [Abstract] [Full Text] [Related]
8. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A, Rasolovavalona T, Rasolofo V, Chanteau S, Ralamboson M, Cauchoix B, Rakotondramarina D. Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578 [Abstract] [Full Text] [Related]
9. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM, Bakare NA, Onadeko BO. Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [Abstract] [Full Text] [Related]
10. Decentralisation of treatment for patients with tuberculosis in Malawi: moving from research to policy and practice. Salaniponi FM, Gausi F, Mphasa N, Nyirenda TE, Kwanjana JH, Harries AD. Int J Tuberc Lung Dis; 2003 Sep; 7(9 Suppl 1):S38-47. PubMed ID: 12971653 [Abstract] [Full Text] [Related]
11. When are follow-up sputum smears actually examined in patients treated for new smear-positive pulmonary tuberculosis? Harries AD, Gausi F, Salaniponi FM. Int J Tuberc Lung Dis; 2004 Apr; 8(4):440-4. PubMed ID: 15141736 [Abstract] [Full Text] [Related]
12. Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision. Banerjee A, Harries AD, Mphasa N, Nyirenda TE, Veen J, Ringdal T, Van Gorkom J, Salaniponi FM. Int J Tuberc Lung Dis; 2000 Apr; 4(4):333-9. PubMed ID: 10777082 [Abstract] [Full Text] [Related]
14. Management and outcome of tuberculosis patients who fail treatment under routine programme conditions in Malawi. Harries AD, Nyirenda TE, Kemp JR, Squire BS, Godfrey-Faussett P, Salaniponi FM. Int J Tuberc Lung Dis; 2003 Nov; 7(11):1040-4. PubMed ID: 14598962 [Abstract] [Full Text] [Related]
15. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. Tam CM, Chan SL, Kam KM, Goodall RL, Mitchison DA. Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398 [Abstract] [Full Text] [Related]
16. Conversion rate at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso. Dembele SM, Ouedraogo HZ, Combary A, Saleri N, Macq J, Dujardin B. Int J Tuberc Lung Dis; 2007 Dec; 11(12):1339-44. PubMed ID: 18034956 [Abstract] [Full Text] [Related]
17. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy]. Xu WG, Gao Z, Fan BD. Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655 [Abstract] [Full Text] [Related]
18. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Swaminathan S, Deivanayagam CN, Rajasekaran S, Venkatesan P, Padmapriyadarsini C, Menon PA, Ponnuraja C, Dilip M. Natl Med J India; 2008 Feb; 21(1):3-8. PubMed ID: 18472696 [Abstract] [Full Text] [Related]
19. Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Hesseling AC, Walzl G, Enarson DA, Carroll NM, Duncan K, Lukey PT, Lombard C, Donald PR, Lawrence KA, Gie RP, van Helden PD, Beyers N. Int J Tuberc Lung Dis; 2010 May; 14(5):560-70. PubMed ID: 20392348 [Abstract] [Full Text] [Related]
20. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako]. Kayantao D, Keïta B, Sangaré S. Bull Soc Pathol Exot; 1997 May; 90(2):124-7. PubMed ID: 9289251 [Abstract] [Full Text] [Related] Page: [Next] [New Search]